Original Research

Accepted on 11 Nov 2024

Interactions of Warfarin with COVID-19 Vaccine/Drugs, Monoclonal Antibodies, and Targeted Anticancer Agents from Real-World Data Mining

in Pharmacoepidemiology

Yan Gao
Qingsong Huang
Jun Li
Junsheng He
Fang Qian
Juanjuan Yi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418997

157 views

Original Research

Accepted on 11 Nov 2024

Anti-migraine medications safety during pregnancy in the US

in Pharmacoepidemiology

Anick Bérard
Shannon Strom
Detlef Albrecht
Shashi Kori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481378

Brief Research Report

Published on 11 Nov 2024

Dispensing of zolpidem and benzodiazepines in Brazilian private pharmacies: a retrospective cohort study from 2014 to 2021

in Pharmacoepidemiology

Fabiana Carvalho
André Comiran Tonon
Maria Paz Hidalgo
Manuela Martins Costa
Sotero Serrate Mengue

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1405838

252 views

Original Research

Accepted on 07 Nov 2024

Cardiovascular Toxicity Risk Assessment of Tyrosine Kinase Inhibitors: A Pharmacovigilance Study Using the VigiBase Database

in Pharmacoepidemiology

Yusuke Igawa
Hirofumi Hamano
Satoru Esumi
Tatsuaki Takeda
Makoto Kajizono
Ryo Kikuoka
Ikuya Kimura
Yoshito Zamami

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472008

Original Research

Published on 07 Nov 2024

Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004–2023)

in Pharmacoepidemiology

Lin Chen
Zhicheng Dai
Huangrong Song
Jiafeng Zhang
Tuo Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1473756

553 views

Original Research

Published on 06 Nov 2024

Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups

in Pharmacoepidemiology

Yingyong Ou
Zhiwei Cui
Siyu Lou
Chengyu Zhu
Junyou Chen
Linmei Zhou
Ruizhen Zhao
Li Wang
Fan Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1463657

741 views

Original Research

Published on 06 Nov 2024

Factors influencing participation of elderly population in mass drug administration for lymphatic filariasis: a cross-sectional study

in Pharmacoepidemiology

Muhammed Jabir
Vijayakumar Balakrishnan
Kaliannagounder Krishnamoorthy
Ashwani Kumar
Philip Raj Abraham

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1429653

362 views

Original Research

Published on 05 Nov 2024

Non-adherence to antidementia medications and associated factors: a study of Spanish population-based registry data

in Pharmacoepidemiology

Eduardo Gutiérrez-Abejón
M. Aránzazu Pedrosa-Naudín
Diego Fernández-Lázaro
Isabel Díaz Planelles
F. Javier Álvarez

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1425442

368 views

Original Research

Published on 01 Nov 2024

Sex bias in prospective follow-up observational studies with drugs carried out in a southern region of Europe

in Pharmacoepidemiology

Àlex Santomà
Anna Maria Jambrina
Adela Perisé
Mercè Armelles
Lluisa Perisé
Clara Pareja
Neus Rams
Manel Rabanal

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1427293

308 views

Original Research

Published on 30 Oct 2024

Prevalence and influence factor of drug-related problems in inpatients with kidney disease: a prospective single central study

in Pharmacoepidemiology

Guoguang Gu
Yanping Li
Yunyun Hu
Hengyi Zhao
Xingdong Wang
Xiaomin Li
Xinran Zhang
Hong Zhu
Xiaohua Dai
Xingxing Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1436561

508 views

Original Research

Published on 30 Oct 2024

Comparing ischemic cardiovascular effectiveness and safety between individual SGLT-2 inhibitors and DPP-4 inhibitors in patients with type 2 diabetes: a nationwide population-based cohort study

in Pharmacoepidemiology

Hayeon Kim
Jun-Ho Seo
Jin Hyun Nam
Yejee Lim
Kyung Hee Choi
Kyungim Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1443175

680 views

Original Research

Published on 28 Oct 2024

Machine learning methods for propensity and disease risk score estimation in high-dimensional data: a plasmode simulation and real-world data cohort analysis

in Pharmacoepidemiology

Yuchen Guo
Victoria Y. Strauss
Martí Català
Annika M. Jödicke
Sara Khalid
Daniel Prieto-Alhambra

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1395707

613 views

Original Research

Published on 22 Oct 2024

Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration

in Pharmacoepidemiology

Jing Zhang
Xiaofen Wang
Yiting Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1471615

872 views

Original Research

Published on 22 Oct 2024

Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS

in Pharmacoepidemiology

Ye Xu
Bin Zhao
Liqun He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438292

650 views

Original Research

Accepted on 21 Oct 2024

Use of non-specific immunoglobulins in Catalonia in three thirdlevel hospitals: a descriptive analysis of a hospital-prescribed medication registry

in Pharmacoepidemiology

Judit Riera-Arnau
Elena Ballarín
Roser Llop
Eva Montané
Pilar Hereu Boher
Guillem Vancells
Nuria Padulles-Zamora
Ana María Barriocanal
Gloria Cardona-Peitx
Carlos Casasnovas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420682

Systematic Review

Published on 17 Oct 2024

Efficacy and safety of traditional Chinese medicine combined with azithromycin sequential therapy for mycoplasma pneumonia among children: a meta-analysis of randomized controlled trials

in Pharmacoepidemiology

Jing Lyu
Fei Fan
Ji Li
Qiong Wang
Xue Tian
Jiaxing Xu
Si Zhang
Bo Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1431706

414 views

Navigation group

Articles

Interactions of Warfarin with COVID-19 Vaccine/Drugs, Monoclonal Antibodies, and Targeted Anticancer Agents from Real-World Data Mining

Anti-migraine medications safety during pregnancy in the US

Dispensing of zolpidem and benzodiazepines in Brazilian private pharmacies: a retrospective cohort study from 2014 to 2021

Cardiovascular Toxicity Risk Assessment of Tyrosine Kinase Inhibitors: A Pharmacovigilance Study Using the VigiBase Database

Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004–2023)

Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups

Factors influencing participation of elderly population in mass drug administration for lymphatic filariasis: a cross-sectional study

Non-adherence to antidementia medications and associated factors: a study of Spanish population-based registry data

Sex bias in prospective follow-up observational studies with drugs carried out in a southern region of Europe

Prevalence and influence factor of drug-related problems in inpatients with kidney disease: a prospective single central study

Comparing ischemic cardiovascular effectiveness and safety between individual SGLT-2 inhibitors and DPP-4 inhibitors in patients with type 2 diabetes: a nationwide population-based cohort study

Machine learning methods for propensity and disease risk score estimation in high-dimensional data: a plasmode simulation and real-world data cohort analysis

Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration

Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS

Use of non-specific immunoglobulins in Catalonia in three thirdlevel hospitals: a descriptive analysis of a hospital-prescribed medication registry

Efficacy and safety of traditional Chinese medicine combined with azithromycin sequential therapy for mycoplasma pneumonia among children: a meta-analysis of randomized controlled trials